His
lifelong passion was to better understand
and improve the treatment of skin
diseases. He lectured in many countries,
received honorary memberships and
awards from dermatological societies
worldwide,authored 225 publications,
and received
the award of Master In Dermatology
from the American Academy of Dermatology. He
collaborated in clinical studies
demonstrating the effectiveness of
the first antihistamine, Benadryl. He
also worked with skin biologists
and clinicians around the world to
establish the International Symposium
on Psoriasis at Stanford in 1971,
as well as one of the first hospital-based
psoriasis day care centers.
From
the beginning, Dr. Farber combined
clinical observation with laboratory
research. He demonstrated that investigative
laboratory studies could expand clinical
knowledge and improve clinical treatments.
He was particularly known for his
using his insightful research to
improve the clinical treatment of
psoriasis. Dr. Farber was also admired
for his ability to teach not only
the science but also the art of dermatology.
Dr.
Farber was a leader of dermatology.
He was on the Board of Directors
of the American Academy of Dermatology,
the American Dermatological Association,
the Association of Professors of
Dermatology, the Pacific Dermatological
Association, and the Society for
Investigative Dermatology. He also
held several editorial positions,
and he served as President of the
Association of Professors of Dermatology,
the Pacific Dermatology Association,
the Society for Investigative Dermatology,
and the Psoriasis Research Institute.
